Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
BBI-825 by Boundless Bio for Solid Tumor: Likelihood of Approval
BBI-825 is under clinical development by Boundless Bio and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
Data Insights
BBI-825 by Boundless Bio for Metastatic Colorectal Cancer: Likelihood of Approval
BBI-825 is under clinical development by Boundless Bio and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...